Objective-Macrophages play a central role in various stages of atherosclerotic plaque formation and progression. The local macrophages reportedly proliferate during atherosclerosis, but the pathophysiological significance of macrophage proliferation in this context remains unclear. Here, we investigated the involvement of local macrophage proliferation during atherosclerosis formation and progression using transgenic mice, in which macrophage proliferation was specifically suppressed. Approach and Results-Inhibition of macrophage proliferation was achieved by inducing the expression of cyclindependent kinase inhibitor 1B, also known as p27 kip , under the regulation of a scavenger receptor promoter/enhancer. The macrophage-specific human p27
A ccumulation of macrophages in damaged vessel walls is a critical process in the pathogenesis of atherosclerosis. Macrophages are activated by various atherogenic factors, including Ox-LDL (oxidized low-density lipoprotein), in subendothelial spaces of the arterial wall. Additionally, macrophages produce chemokines, cytokines, and growth factors, thereby, initiating the formation and progression of earlyphase atherosclerosis. [1] [2] [3] In advanced lesions, an increase in the number of macrophage-derived foam cells substantially impacts the progression of atheromatous plaques. 4 In lesions, macrophage number is determined by the balance between monocyte recruitment and macrophage proliferation, on the one hand, and macrophage death and egress from the lesion, on the other. 5 The involvement of proliferating macrophages in atherosclerotic plaque formation and progression has been demonstrated as one of the most prominent features promoting atherosclerosis in animal models and humans. 6, 7 Ox-LDL is one of the major physiologically active substances that promotes atherosclerotic plaque formation and progression during inflammatory response, phagocytosis, chemotaxis, and macrophage proliferation. 3 We previously showed that Ox-LDL enhanced macrophage proliferation, and incorporation of Ox-LDL via the scavenger receptor was key for activating signals promoting macrophage proliferation. 8, 9 Inhibition of macrophage proliferation in atherosclerotic plaque, through genetic modifications and pharmacological agents, has revealed the importance of macrophage proliferation in plaque formation and progression. 10, 11 We previously reported that administration of statins, angiotensin receptor blockers, thiazolidinediones, or a 5′ AMP-activated protein kinase activator to apolipoprotein E-deficient (ApoE −/− ) mice inhibited macrophage proliferation and resulted in the prevention of atherosclerotic plaque formation and progression in vivo. Therefore, proliferating macrophages could play an important role in the promotion of atherosclerotic plaque formation. [12] [13] [14] [15] Because these genetic or pharmacological approaches may affect other atherogenic macrophage functions, as well as inhibit their proliferation, the extent to which macrophage proliferation is primarily involved in inflammation of these tissues has remained unresolved.
In this study, we tested whether suppression of macrophage proliferation helped prevent atherosclerosis progression or plaque stabilization. To this end, we generated transgenic (Tg) mice selectively expressing human p27 kip (cyclin-dependent kinase inhibitor 1B) in macrophages. We report that expression of p27 kip suppressed macrophage proliferation without altering their other functions and blocked progression of atherosclerosis in ApoE −/− mice. These results provide direct evidence of the involvement of local macrophage proliferation in chronic tissue inflammation and as a common pathophysiological feature characterizing the formation, progression, and stabilization of atherosclerotic plaques.
Materials and Methods

Animals
The macrophage-specific human p27
kip Tg (mac-p27Tg) mouse line was designed to induce the expression of human p27 kip under the regulation of the SR-AI (scavenger receptor-AI) promoter/enhancer. Full-length cDNA encoding the human p27 kip gene with a FLAGtag fused at the 5′ end 16 was subcloned into a plasmid behind the SR-AI enhancer/promoter (5.0 kb), which was kindly provided by Christopher K. Glass (University of California, San Diego, CA), 17 and in front of the human growth hormone poly (A + ) tail (5.6 kb). The construct was purified and microinjected into mouse embryos ( Figure  IA in the online-only Data Supplement). The mac-p27Tg mice were crossed with ApoE −/− animals for the atherosclerotic plaque study. All mice were male C57BL/6J ApoE −/− mice with a C57BL/6J background and were purchased from Jackson Laboratory (Bar Harbor, ME). All animal procedures were conducted according to the Guide for the Care and Use of Laboratory Animals issued by the Animal Research Committee at Kumamoto University (Kumamoto, Japan). Experimental procedures were approved by the Ethics Committee on Animal Experiments, Faculty of Life Sciences, Kumamoto University (Permit Number: A27-040). Mice were anesthetized with isoflurane and then killed by cervical dislocation.
We have preliminarily studied the plaque formation and the effect of macrophage proliferation inhibition in 20-week-old male and female ApoE −/− and Tg-ApoE −/− mice. Atherosclerotic plaque formation was comparable in male and female ApoE −/− mice (414 836 versus 483 629 µm 2 ; P=0.291), and Tg-ApoE −/− mice showed significantly inhibited plaque formation and progression in both males and females (data not shown).
Cell Culture
The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Kumamoto University. Peritoneal macrophages were collected from male wild-type (WT) or mac-p27Tg mice and cultured in complete DMEM with 25.0 mmol/L glucose (Wako, Osaka, Japan) and supplemented with 10% fetal bovine serum and an antibiotic-antimycotic mixed stock solution (Nacalai Tesque, Kyoto, Japan). Cells were maintained in 5% CO 2 and 95% air at 37°C. Similarly, bone marrow-derived macrophages (BMMs) from male WT or mac-p27Tg mice were cultured in complete medium supplemented with 20% L-Cell-conditioned medium as a source of macrophage colony-stimulating factor.
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Lipopolysaccharide-Induced Inflammation of Macrophages
Bone marrow cells were extracted from male mac-p27Tg and WT mice and cultured in medium for 7 days to induce differentiation into BMMs. BMMs were stimulated with 1.0 ng/mL lipopolysaccharide for 2 hours, followed by RNA extraction.
Lipoprotein Preparation and LDL Oxidation
Human LDL (low-density lipoprotein; d=1.019-1.063 g/mL) was isolated by sequential ultracentrifugation from the plasma of consenting normolipidemic subjects after overnight fasting and dialyzed against 0.15 mol/L NaCl and 1 mmol/L EDTA (pH 7.4). Ox-LDL was prepared by incubating LDL with 5 mol/L CuSO 4 for 20 hours at 37°C, followed by the addition of 1 mmol/L EDTA and cooling. Protein concentrations were determined using a Bio-Rad protein assay kit (Bio-Rad Laboratories, Watford, Hertfordshire, United Kingdom).
Measurement of Blood Parameters
Blood samples from mice were taken early in the morning during the fasting state before euthanasia. Serum total cholesterol, triglycerides, LDL cholesterol, high-density lipoprotein cholesterol, and fasting glucose levels were measured using a BioMajesty JCA-BM6050 analyzer (Japan Electron Optics Laboratory, Tokyo, Japan) at the Kumamoto Mouse Clinic, Institute of Resource Development and Analysis, Kumamoto University.
Blood Count
Monocyte counts were analyzed on a counter (ADVIA 2120i; Siemens, Erlangen, Germany) at the Kumamoto Mouse Clinic, Institute of Resource Development and Analysis, Kumamoto University.
Quantitative Reverse Transcription Polymerase Chain Reaction Analysis
Total RNA from BMMs was isolated using the RNeasy mini kit (74104; Qiagen, Santa Clarita, CA); total RNA of the aortic arch was extracted with the RNeasy lipid tissue kit (74804; Qiagen); and total RNA from plaque sections was extracted with the RNeasy micro kit (74004; Qiagen). First-strand cDNA was synthesized using ReverTra Ace (FSQ-201; Toyobo, Osaka, Japan). Quantitative polymerase chain reaction was performed using GoTaq qPCR master mix (A6001; Promega, Mannheim, Germany) in an ABI 7300 real-time polymerase chain reaction system (Applied Biosystems, Foster City, CA). Quantitative mRNA results were normalized to 18S mRNA. To assess the specificity of the amplified polymerase chain reaction products, a dissociation curve analysis was performed after the last amplification cycle. Primers used in this study are listed in Table II in the online-only Data Supplement.
Cell Proliferation Assay
To quantify cell proliferation of cultured BMMs and peritoneal primary macrophages (PPMs), a CCK-8 assay (347-07621; Dojindo, Kumamoto, Japan) and the cellular bromodeoxyuridine ELISA kit (CY-1142; CycLex, Nagano, Japan) were used according to manufacturer's instructions. Proliferation during BMM differentiation was evaluated using the CCK-8 assay on days 3, 5, and 7 after plating. Ox-LDL or granulocyte colony stimulating factor-induced macrophage proliferation was assessed using the CCK-8 assay on day 6 after growth stimulation.
Macrophage-Migration Assay
The macrophage-migration assay was performed using a CytoSelect 96-well cell migration assay kit (Cell Biolabs, San Diego, CA) according to manufacturer's instructions. PPMs (6×10 5 /well) from WT and mac-p27Tg mice were washed and plated in the membrane chamber (5-μm pore size), which was placed on top of the feeder tray. Cells were incubated with 20 ng/mL recombinant mouse MCP-1 (monocyte chemoattractant protein-1; 200-39; Shenandoah Biotechnology, Warwick, PA) at 37°C for 14 hours. Migrating cells were dissociated from the membrane, lysed, and quantified using CyQuant GR dye under a fluorescence microscope.
Cellular Cholesterol Efflux Assay
Cholesterol efflux was measured by the transfer of [ 3 H] cholesterol from cells to culture medium, as described previously. 19 Cholesterol efflux capacity was assessed on confluent monolayers of peritoneal macrophages from WT and Tg mice. These were radiolabeled for 48 hours with 0.5 μCi [ Finally, BMMs were exposed to TO-901317(1 μmol/L) for 24 hours, and mRNA expression of cholesterol efflux regulatory proteins/mediators ABCA1 (ATP-binding cassette transporter A1) and ABCG1 (ATP-binding cassette transporter G1) was evaluated.
Oil Red O Staining of Macrophages
BMMs were incubated in DMEM supplemented with 20 μg/mL Ox-LDL for 24 hours, and lipid accumulation was evaluated by Oil Red O staining. Briefly, BMMs were fixed in 10% formaldehyde, washed in 60% isopropanol, and stained with 0.3% Oil Red O. Results were examined using a BZ-X700 confocal fluorescence microscope (KEYENCE, Osaka, Japan).
Apoptosis of Macrophages
PPMs were treated with thapsigargin (1 µmol/L) for 24 hours. After treatment, PPMs were collected from the medium, washed with PBS, and fixed with 4% formalin. Cells were stained with F4/80 (1:200) and 4′,6-diamidino-2-phenylindole (DAPI, 1:200) for 30 minutes on ice, after which the percentage of PPMs in sub-G phase was determined with a cell sorter (SH800; Sony, Tokyo, Japan). Data were evaluated with FlowJo v10 (Tree Star, Inc., Portland, OR).
Western Blot Analysis
Macrophages were lysed in 0.5% CHAPS lysis buffer. Equal amounts of protein were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred onto polyvinylidene fluoride membranes. Membranes were probed with purified mouse anti-p27 
Quantification of Atherosclerotic Lesions in the Aortic Sinus
For quantitative analysis of atherosclerotic lesions in the aortic sinus of 16-, 20-, and 24-week-old ApoE −/− or mac-p27Tg mice, the hearts were cut in half, and the top half and aortic root were perfused with 10% buffered formalin. Next, tissues were frozen in optimal cutting temperature compound (4583; Sakura Finetechnical, Tokyo, Japan) after equilibration in 20% sucrose, after which 5-μm-thick cross sections were taken sequentially from just above the aortic valve using a cryostat and stained with Oil red O and hematoxylin and eosin. The necrotic core area was quantified by measuring the clear acellular/anuclear areas, and the ratio with respect to total plaque area was calculated.
For en face analysis of atherosclerotic lesions, the aortas were excised from the root to the abdominal area, and the connective and adipose tissues were manually removed from the aorta. The entire aorta was stained with Oil red O, and the atherosclerotic lesions of the aortic valves and whole aortas were histologically analyzed under a BZ-X700 confocal fluorescence microscope (KEYENCE, Osaka, Japan). The extent of whole aortic atherosclerotic lesion development was determined as a percentage of the total area of the aorta that was occupied by Oil red O-positive atherosclerotic lesions.
Laser Microdissection
The heart and aortic root were excised from 16-and 24-week-old ApoE −/− or Tg-ApoE −/− mice. The hearts were cut in half, and the top half and aortic root were embedded and frozen in optimal cutting temperature compound. Cross sections (8-µm thick) were taken sequentially from just above the aortic valve throughout the aortic sinus using a cryostat. After sections were stained with toluidine blue, the plaques were laser microdissected (laser settings: power 20/60, aperture 15/50, and speed 8/100) and collected in a 0.2-mL microfuge tube containing RNeasy lysis buffer for subsequent total RNA extraction.
Immunohistochemistry
The aortic valve throughout the aortic sinus was fixed with neutralbuffered 10% formalin and embedded in paraffin. The sections were stained with Masson's trichrome and the following mouse monoclonal antibodies: anti-Iba-1 (1:1000, 019-19741; Wako), anti-Ki67 (418071; Nichirei Bioscience, Tokyo, Japan), and anti-α-smooth muscle actin (α-SMA; 1:100, IS61130-2; DAKO, Carpinteria, CA), F4/80 (1:100, MCA497R; AbD Serotec, Oxford, United Kingdom), CD31 (1:50, 550274, BD Pharmingen, San Jose, CA), and FLAG polyclonal antibody (1:100, F7425; Sigma-Aldrich). To identify macrophage proliferation, Ki67/Iba-1 and Ki67/F4/80 double immunohistochemical stainings were performed. To stain Ki67/Iba-1, the tissues were incubated for 1.5 hours at room temperature with the anti-Ki67 antibody and visualized by 3,3′-diaminobenzidine staining (Nichirei Bioscience). After sections were rinsed with 100 mmol/L glycine-HCl buffer (pH 2.2) to remove the first and second antibodies, they were incubated with the anti-Iba-1 antibody overnight at 4°C. Visualization of the reaction was performed using HistoGreen (Cosmobio, Tokyo, Japan) in 50 mmol/L Tris-HCl buffer (pH 8.5), which produced a green color. Negative controls using the corresponding IgG (FLEX Negative Control Rabbit, IS600; DAKO) were included to check for nonspecific staining. α-SMA was stained with the Warp Red chromogen kit (Biocare Medical, Concord, CA).
On the other hand, Ki67 and F4/80 were performed to immunofluorescence staining to identify macrophage proliferation. FLAG, α-SMA, and CD31 were also performed to immunofluorescence staining to check for no FLAG signal in the area of CD31 and α-SMA-positive cells on the plaque.
Immunostainings were histologically analyzed under a BZ-X700 confocal fluorescence microscopy (KEYENCE).
Flow Cytometry
Peripheral blood for flow cytometric analysis was collected from the tail vein using 50 mmol/L EDTA as an anticoagulant. The blood was collected from the 20-week-old male WT and Tg mice. Erythrocytes were lysed using RBC Lysis Buffer (420301; BioLegend, San Diego, CA). For aortic tissue, the entire aorta was digested (from the root to the iliac bifurcation) according to a previously published method. 20 Accordingly, the aorta of 18-week-old female ApoE −/− and Tg-ApoE −/− mouse was perfused with 20 mL PBS before digestion.
Aortic tissue was cut in small pieces and subjected to enzymatic digestion with 450 U/mL collagenase I, 125 U/mL collagenase XI (C130; Sigma-Aldrich), 60 U/mL DNase I (AMPD1-1KT; SigmaAldrich), and 60 U/mL hyaluronidase (H3757; Sigma-Aldrich) for 1 hour at 37°C. The following antibodies were used for flow cytometric analyses: CD90-phycoerythrin (PE; 553005, clone 53-2.1), CD45R/ B220-PE (561878, clone RA3-6B2), CD49b-PE (561066, clone DX5), NK1.1-PE (561046, clone PK136), Ly-6G-PE (561104, clone 1A8), Ter119-PE (561071, clone TER119), CD11b-peridinin chlorophyll protein complex CD11b-PerCP-Cy5.5 (561114, clone M1/70), CD11c-allophycocyanin (117309, clone HL3), Ly-6C-fluorescein isothiocyanate (561085, clone AL-21; all BD Biosciences, Franklin Lakes, NJ), and F4/80-PE-Cy7 (clone BM8; BioLegend). Antibody dilutions were in the range of 1:100. Cell-cycle analysis based on DAPI staining was performed using FxCycle violet stain (D212; Dojindo). Monocytes and macrophages were identified using a method similar to one described previously. 21 . Data were acquired on a SH800 cell sorter and analyzed with FlowJo v10.
Bone Marrow Transplantation
Bone marrow cells were extracted from the femoral and tibia bones of 8-week-old male ApoE −/− or Tg-ApoE −/− mice and resuspended in Dulbecco's modified Eagle medium. Host (8-week-old) male mice received 9.1 Gy of whole-body γ-irradiation, and subsequently, bone marrow cells were transplanted via tail-vein infusion (7.5×10 6 /0.5 mL total volume). Twelve weeks after transplantation, atherosclerotic lesions in the aortic sinus were quantified by Oil red O hematoxylin and eosin staining.
The transplantation rate was assessed by immunofluorescence staining against the FLAG-tag protein and F4/80 in BMMs. BMMs were fixed with 4% formalin and permeabilized with cold methanol at −20°C for 10 minutes, rinsed with PBS, and incubated with a rabbit anti-FLAG polyclonal antibody (1:100; F7425; Sigma-Aldrich, St Louis, MO) and a rat anti-mouse F4/80 antibody (1:100; MCA497R; AbD Serotec, Oxford, United Kingdom) for 1.5 hours at room temperature. Negative controls using the corresponding IgG (FLEX negative control rabbit and rat IgG2b negative control, MCA6006GA; Bio-Rad Laboratories) were included to check for nonspecific staining. Cells were treated with secondary antibodies conjugated to Alexa Fluor 488 (1:200; A11034; Molecular Probes, Eugene, OR) and Alexa Fluor 546 (1:200; A11081; Molecular Probes) for 1 hour. After adding DAPI, cells were observed under a microscope (BZ-X700; KEYENCE), and the coincidence ratio between F4/80 and FLAG was evaluated.
Statistical Analysis
Results are expressed as the mean±standard error of the mean. All data were assessed for normality/equal variance using the F test and the Shapiro-Wilk test in SPSS software (IBM, Chicago, IL). Comparisons between groups were conducted using t test and Tukey multiple-comparison test. The nonparametric Mann-Whitney test was used to compare data that did not follow a normal distribution or equal variance. P values <0.05 were considered statistically significant.
Results
Generation of Tg Mice With MacrophageSpecific Proliferation Inhibition
To investigate the implications of local macrophage proliferation on tissue inflammation in vivo, we generated mac-p27Tg exhibiting selective inhibition of macrophage proliferation. Full-length cDNA corresponding to the human p27 kip -encoding gene was subcloned into a plasmid containing the human scavenger receptor A-I enhancer/promoter (5.0 kb; Figure 1A ). The scavenger receptor A-I promoter/enhancer plasmid (pAL-1) enables highly specific gene expression in differentiated macrophages. 17, 22 We obtained 5 Tg founders, and for this series of experiments, out of 3 Tg lines exhibiting normal fertility ratios, we selected the one with the lowest p27 kip protein expression in macrophages, but which still ensured inhibition of macrophage proliferation ( Figure I in the online-only Data Supplement).
The specificity of p27 kip expression in cells of the atherosclerotic plaque was evaluated by double immunofluorescence staining against FLAG tag for exogenous expression Figure 1 Continued. C, Cell counts during BMM differentiation on days 3, 5, and 7 after plating (left). BMM proliferation according to the bromodeoxyuridine assay on day 7 (n=4 per group; right). D, Peritoneal primary macrophage (PPM) proliferation on day 6 after growth stimulation by Ox-LDL (oxidized low-density lipoprotein; 20 μg/mL; n=8 per group; left). PPM proliferation on day 6 after growth stimulation by granulocyte-macrophage colony-stimulating factor (GM-CSF; 2 nmol/L; n=4 per group; right). Data are expressed relative to controls. Error bars represent the standard error of the mean. P values for C (left) are from t tests and Tukey multiple-comparison test.
Other P values are from t tests.*P<0.05, **P<0.01. hGH indicates human growth hormone.
of FLAG-p27 kip and against α-SMA for smooth muscle cells. No merged signals could be detected with FLAG and α-SMA. Endothelial cells were stained with CD31 antibody in serial section of FLAG staining. There was no FLAG signal detected in the area of CD31-positive endothelial cells on plaque surface ( Figure IC in the online-only Data Supplement). Results showed that exogenous p27 kip expression was strictly limited to macrophages.
Both mRNA and protein expression of human p27 kip were significantly elevated in cultured bone marrow cells of macp27Tg mice when compared with WT mice after differentiation into macrophages ( Figure 1B) . PPM showed abundant endogenous p27 kip protein. Endogenous p27 kip protein was also detected in nonproliferating BMMs cultured in LCM (L-cellconditioned medium)-deprived culture medium ( Figure IC in the online-only Data Supplement). When BMMs were proliferating in LCM-containing culture medium, the p27 kip protein level was markedly reduced, and p27 kip was hardly detected in the proliferating condition (Figure 1B , bottom; Figure IC in the online-only Data Supplement).
By contrast, their proliferation was significantly inhibited as determined by counting the number of live cells and the bromodeoxyuridine incorporation assay ( Figure 1C ). Ox-LDL and granulocyte-macrophage colony-stimulating factor-induced primary peritoneal macrophage proliferation was also significantly inhibited in mac-p27Tg mice as compared with WT mice ( Figure 1D ). There were no significant differences in MCP-1-induced chemotaxis ( Figure IIA 
Impact of Macrophage Proliferation Inhibition on Atherosclerotic Plaque Formation and Progression
To verify the direct involvement of local macrophage proliferation in atherosclerotic plaque formation and progression, mac-p27Tg and ApoE −/− mice were crossed (Tg-ApoE We also performed flow cytometry analysis on circulating monocytes. Comparable to the number of monocytes in the blood shown in Figure VB in the online-only Data Supplement, flow cytometry revealed that the number of monocytes was generally higher in Tg mice, albeit not significantly ( Figure  VIA and VIB, top, in the online-only Data Supplement). DNA content analysis using DAPI showed no significant difference between WT and Tg animals, suggesting that there is no monocyte proliferation altered with SR-A (scavenger receptor-A) promotor/enhancer-driven p27 kip expression ( Figure VIC and VID in the online-only Data Supplement). We also evaluated Ly-6C expression in circulating monocytes in WT and Tg mice. There was no significant difference in the proportion of Ly-6C high and Ly-6C low monocytes between WT and Tg mice. This information has been added in Figure  VIB , bottom, in the online-only Data Supplement. No significant difference in basal metabolic parameters (total cholesterol, triglycerides, high-density lipoprotein cholesterol, LDL cholesterol, and blood glucose levels) was observed between ApoE −/− and Tg-ApoE −/− mice ( Table I in the online-only Data Supplement).
Therefore, we concluded that scavenger receptor A-I promoter/enhancer-driven p27 kip overexpression in differentiated macrophages did not affect the number of monocytes or major macrophage functions related to atherosclerotic plaque formation. To assess the involvement of macrophage proliferation in atherosclerotic lesions, we performed double staining against macrophage-specific Iba-1 and F4/80 and the proliferation marker Ki67 (Figure 2A and 2B) . Consistent with our previous results, we observed Ki67-positive proliferating macrophages in the plaque of ApoE −/− mice, but these were significantly fewer in the plaque of Tg-ApoE −/− animals. Specifically, there were 46.4% fewer Ki67-positive nuclei in Iba-1 macrophages in the plaque of Tg-ApoE −/− mice (7.64±2.35%) than in control ApoE −/− mice (14.24±1.73%; P=0.026; Figure 2A ). We also performed flow cytometry analysis to assess macrophage proliferation in aortic tissue. Tissue macrophages were selected using F4/80 antibodies, and proliferation was evaluated by DNA content using DAPI staining. Proliferating macrophages in the S/G2/M phases of the cell cycle were significantly fewer in Tg-ApoE −/− aortic tissue than in ApoE −/− tissue ( Figure 2C and 2D) . 
Effect of Macrophage Proliferation on the Plaque Inflammatory Response
Atherosclerotic plaques were selectively dissected using laser microdissection, and the total RNA was extracted. A comparison of Tg-ApoE −/− mice with control ApoE −/− mice revealed that mRNA expression of CD68 and CD11c decreased significantly, whereas expression of the M2 macrophage marker CD204 did not differ between ApoE −/− and Tg-ApoE −/− mice. The mRNA expression of MCP-1 and IL-6 decreased significantly in Tg-ApoE −/− and that of IL-1β was generally reduced. The mRNA expression of IL-1β and IL-6 was also significantly lower, whereas TGF-β (transforming growth factor-β) mRNA expression was significantly increased in the entire aortic arch in Tg-ApoE −/− animals ( Figure 3C ). These findings suggested that macrophage-specific inhibition of proliferation resulted in fewer inflammatory macrophages and also indicated a relative increase in the ratio of anti-inflammatory M2 macrophages with respect to total macrophages in the atherosclerotic plaque.
Involvement of Macrophage Proliferation in Advanced Lesion Formation
We then assessed the impact of inhibiting macrophage proliferation on advanced atherosclerotic lesion progression in 24-week-old ApoE −/− and Tg-ApoE −/− mice. At 24 weeks, we observed significant suppression of plaque-area size (ApoE 
Macrophage Proliferation and Plaque Stability
To further assess the involvement of macrophage proliferation inhibition in atherosclerotic plaque progression from an early to an advanced stage, we analyzed plaque lesions in 16-, 20-, and 24-week-old mice. As shown in Figure 2B and 2C, atherosclerotic plaque size and necrotic core formation ratio in the plaque increased with age in control ApoE −/− mice, whereas Tg-ApoE −/− mice showed significant inhibition of atherosclerotic plaque formation at all time points. However, the difference in plaque area between control ApoE −/− and Tg-ApoE −/− mice became smaller during the advanced stages ( Figure 4C ). Necrotic core formation in the plaque, which is a key feature of atherosclerotic plaque instability, was significantly inhibited in Tg-ApoE −/− mice, particularly at 20 and 24 weeks of age ( Figure 4D ). These results suggest that macrophage proliferation was involved in all stages of atherosclerotic plaque formation. Moreover, reducing macrophage proliferation was particularly effective at preventing plaque instability in advanced lesions.
To demonstrate the effect of fewer macrophages on advanced lesion progression, we examined collagen and smooth muscle cell content and metalloproteinase expression in the plaque area of Tg-ApoE −/− and control ApoE −/− mice. Luminal fibrous caps on remodeled atherosclerotic plaques are composed mainly of vascular smooth muscle cells and a collagenous extracellular matrix, and evidence suggests that thicker fibrous caps are less prone to rupture. [23] [24] [25] [26] Masson's trichrome staining revealed a significant increase in collagen-positive areas in plaque (ApoE Figure 5B ). In atherosclerotic plaque lesions selectively dissected by laser microdissection, mRNA expression of collagen type 1A1 increased significantly, that of α-SMA showed no significant variation, and that of matrix metalloproteinase 2 decreased significantly in Tg-ApoE −/− mice relative to control ApoE −/− animals ( Figure 5C ). These histological and gene expression patterns suggested that macrophage proliferation inhibition contributed to thicken the fibrous cap, increased collagen and smooth muscle cell contents, and inhibited matrix metalloproteinase expression in advanced atherosclerotic lesions.
Efficacy of Macrophage Growth Inhibition on Plaque Formation
To further investigate whether acquired macrophage growth inhibition suppressed atherosclerotic plaque formation, we performed bone marrow transplantation experiments ( Figure 6A ). Our results showed that plaque formation in ApoE −/− mice was significantly suppressed by bone marrow transplantation from Tg-ApoE −/− donors. By contrast, Tg-ApoE −/− mice subjected to the same procedure appeared to form atherosclerotic plaques comparable to those of ApoE 
Discussion
Macrophages play a critical role in atherosclerosis because of their potential to accumulate large amounts of lipids and form foam cells, which are hallmarks of atherosclerotic lesions. Infiltrated monocytes differentiate into macrophages and gradually promote the development of atherosclerotic lesions. These fully differentiated macrophages are thought to have lost their ability to proliferate. At the same time, macrophage proliferation has been identified in the atherosclerotic lesions of humans and mice, and tissue macrophages have been reported to increase in number not only due to monocyte migration but also due to the proliferation of macrophages themselves in the lesions. We and others showed the importance of macrophage proliferation in atherosclerotic plaque formation and progression, and a substantial body of evidence indicates that macrophages proliferate in atherosclerotic plaques and that inhibition of this process is associated with suppressed plaque formation. [10] [11] [12] [13] [14] [15] However, these studies used genetic manipulation or administration of pharmacological agents, which might have altered other macrophage functions in addition to inhibiting their proliferation. This led us to ask how and to what extent local macrophage proliferation contributed to atherosclerosis pathophysiology. To directly verify that macrophage proliferation was primarily involved in atherosclerosis and to study its involvement in systemic insulin sensitivity, we generated macrophage-specific human p27 kip Tg mice. In this model, macrophage proliferation was selectively inhibited by p27 kip overexpression. We previously reported that cyclin-dependent kinase inhibitors, including p27 kip , were downregulated in growthstimulated macrophages and upregulated by treatment with 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside, which inhibits macrophage proliferation by blocking cellcycle progression. 15 Decorin administration is reported to induce p27 kip expression in macrophages and inhibits their proliferation. 27 Díez-Juan et al 28 showed that transplantation of p27 kip -deficient bone marrow to ApoE −/− mice enhanced the inflammatory/proliferative response induced by dietary cholesterol and accelerated atherosclerosis. These reports suggest that endogenous p27 kip regulation could be a target for inhibiting cell proliferation and thereby preventing atherosclerosis progression.
To test whether proliferating macrophages promote atherosclerosis formation and progression, or whether inhibiting local macrophage proliferation could be a therapeutic target for atherosclerosis, we performed a bone marrow transplantation study, whereby proliferating or nonproliferating macrophages were transferred to ApoE −/− and Tg-ApoE −/− mice. Tg-ApoE −/− mice transplanted with bone marrow containing replicating macrophages exhibited accelerated atherosclerotic plaque formation, comparable to that in ApoE −/− mice. By contrast, transplantation of growth-inhibited macrophages had a clear inhibitory effect on atherosclerotic plaque formation in ApoE −/− mice. These results suggest that promotion of macrophage proliferation is definitely involved in atherosclerotic plaque formation and that targeted macrophage growth inhibition by pharmacological agents could effectively revert atherosclerotic plaque formation and progression.
We inhibited specific macrophages proliferation and evaluated early or established atherosclerosis in 16-and 24-weekold ApoE −/− mice. Macrophage proliferation inhibition had a more pronounced effect on plaque stability in advanced lesions than on plaque formation or size progression. Our findings are consistent with a previous report by Robbins et al 29 indicating that in the progressed atherosclerosis plaque, macrophage turnover depended by ≤87% on local proliferation of macrophages in lesions and only to a minor extent on monocyte recruitment.
Plaque rupture is not related to the degree of stenosis in the blood vessel but rather to the property of the plaque in the lesion. The plaque is destabilized because of decomposition of its matrix and cell death of smooth muscle cells, which form a thin and brittle fibrous cap. Previous studies reported that macrophage accumulation and plaque destabilization were inhibited through suppression of monocyte infiltration/ activation by MCP deletion. 30, 31 In the present study, macrophage accumulation and excessive inflammatory responses were suppressed in atherosclerotic lesions by direct inhibition of macrophage proliferation. Suppression of excessive inflammation accompanying inhibition of macrophage proliferation might have resulted in reductions in the necrotic core, increased collagen content, and preventing fibrous cap thinning through secretion of proteolytic enzymes, such as matrix metalloproteinase 2.
After inhibition of macrophage proliferation, the M2 antiinflammatory macrophage ratio was seen to increase in the atherosclerotic plaque. At this point, it could be argued that inhibition of macrophage proliferation by p27 kip expression itself promoted the transformation of macrophages to M1 or M2. In the basal culture condition, bone marrow cells were differentiated in L-Cell-conditioned culture medium, which contained macrophage colony-stimulating factor, a known inducer of M2 macrophage polarization in cultured macrophages. As shown in Figure IIB in the online-only Data Supplement, in basal conditions without lipopolysaccharide stimulation, there was no change in M2 macrophage marker (Arg, Mgl-1, and Mgl-2) mRNA expression between macrophages from WT and Tg mice. After lipopolysaccharide treatment, mRNA expression of inflammatory cytokines (MCP-1, IL-1β, TNF-α, and IL-6) was markedly increased, yet no difference between macrophages from WT and Tg mice could be detected. These results suggest that p27 kip expression itself does not induce the preferential transformation of macrophages to either the M1 or M2 type. In the case of macrophage proliferation inhibition, a reduced number of macrophages simply neutralizes the excess inflammatory response in the plaque, after which a relative increase in the M2 macrophage population occurs.
In conclusion, inhibition of local macrophage proliferation resulted in a marked suppression of atherosclerotic plaque formation and progression in ApoE −/− mice. Our results suggest that local macrophage proliferation could be a common pathophysiological feature underlying atherosclerotic plaque formation, progression, and plaque stability. These findings indicate that control of macrophage proliferation might represent a therapeutic target for treating atherosclerotic diseases.
